Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cellular and molecular characterization of renal cell carcinoma

ABSTRACT: Cellular and molecular characterization of renal cell carcinoma

PROVIDER: PRJNA671296 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Cellular and molecular characterization of renal cell carcinoma

Project description:Cellular and molecular characterization of renal cell carcinoma

| PRJNA671297 | ENA

Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma

Project description:Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma

| PRJNA780561 | ENA

Clinical and Molecular Characterization of KRAS Mutations in Renal Cell Carcinoma

Project description:Clinical and Molecular Characterization of KRAS Mutations in Renal Cell Carcinoma

| PRJNA1336533 | ENA

Comprehensive genomic characterization of translocation renal cell carcinoma.

Project description:Comprehensive genomic characterization of translocation renal cell carcinoma.

| PRJNA865001 | ENA

Comprehensive genomic characterization of translocation renal cell carcinoma.

Project description:Comprehensive genomic characterization of translocation renal cell carcinoma.

| PRJNA865000 | ENA

Molecular characterization of clonal human renal forming cells

Project description:Molecular characterization of clonal human renal forming cells

| PRJNA605264 | ENA

Genomic characterization of Chinese clear cell renal cell carcinoma

Project description:Genomic characterization of Chinese clear cell renal cell carcinoma

| PRJNA523858 | ENA

Clinical and Molecular Characterization of KRAS Mutations in Renal Cell Carcinoma

Project description:KRAS mutations in renal cell carcinoma (RCC) are rare and are associated with the histologic subtype "papillary renal neoplasm with reverse polarity" (PRNRP). Despite this association, the broader clinical and molecular implications of KRAS mutation in RCC are not well understood. This study aimed to characterize the clinical and molecular features of KRAS-mutated RCC. KRAS-mutant RCC patients were identified within the Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) and The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma (TCGA-KIRP) repository. Fraction and allele-specific copy number estimates from tumor sequencing (FACETS) was performed to obtain copy number alterations. Available samples were used for immunohistochemistry and RNA-sequencing analysis. Seventeen patients were included. Three distinct KRAS-mutant RCC subtypes were identified: KRAS-mutant PRCC (35%), KRAS-mutant URCC (35%), and PRNRP (29%). Seven patients (41%) had metastatic disease; none were PRNRP. RNAseq-based deconvolution analysis revealed that PRNRP had enrichment in distal nephron components, whereas KRAS-mutant PRCC was enriched in proximal tubule cells (p = 0.02). IHC staining of L1CAM was positive in PRNRP but negative in KRAS-mutant PRCC, supporting their distinct cell-of-origin phenotypes. This study is limited by its cohort size, which influences the availability of tissue samples. PRNRP represents a distinct KRAS-mutant RCC subtype with unique metabolic and genomic features linked to its distal nephron origin. This contrasts with the genomic complexity and aggressive clinical behavior observed in KRAS-mutant PRCC and URCC, highlighting the need for subtype-specific diagnostic criteria and therapeutic strategies.

2025-12-17 | GSE309610 | GEO

Molecular analysis of renal cell carcinoma with unclassfied histology

Project description:Molecular analysis of renal cell carcinoma with unclassfied histology

| PRJNA339856 | ENA

Genome-wide gene expression profiles of clear cell renal cell carcinoma; Identification of molecular targets for treatment of renal cell carcinoma

Project description:In order to clarify the molecular mechanism involved in renal carcinogenesis, and identify molecular targets for diagnosis and treatment, we analyzed genome-wide gene expression profiles of 15 surgical specimens of clear cell renal cell carcinoma (RCC), compared to normal renal cortex, using a combination of laser microbeam microdissection (LMM) with a cDNA microarray representing 27,648 genes.

2012-07-16 | GSE39364 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data